<!DOCTYPE html><html lang="en" class="bg-surface-base antialiased"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1, interactive-widget=resizes-content"/><link rel="stylesheet" href="/_next/static/css/62c4caba71dfda84.css" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/eb3d87f98fe1565f.css" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/1b5e561215938d4d.css" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/0227d069a630d414.css" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/f87fff2ab93d05a7.css" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh" href="/_next/static/chunks/webpack-e121ed42680f327e.js"/><script src="/_next/static/chunks/78a669d9-e7993486b22c4915.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/40c4a5a7-abdabb07419d1cfc.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/2230-f7c87dc9fa57c408.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/main-app-536d4b8fca62396a.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/63f0ec43-8ee6a76d70472249.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/7670-7326298c9856172b.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/282-691fffb366e24ca5.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/7515-336759ef5dad2b52.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/927-34e2a6da3e15e26b.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/5855-243eeca8f0e4cabd.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/4393-1c8dff25ec904469.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/2225-454cf9f44775e7ce.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/7618-43536a8fb0dd3bfe.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/7720-3a1e7e411adba2d3.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/7086-1f1c4891d766e04f.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/app/global-error-4d07d20223cd4b4c.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/8208b75a-a48e5a4507a0de91.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/5497-ab85ef3ea59dd353.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/6281-c6e84786dade3614.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/2660-d983a7f287e89f18.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/5002-9735c25beda556ba.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/3655-6717081f7512305a.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/8945-e4e3cf487f5e27c7.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/9214-a10614844a67ba31.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/4789-2080f6497f78b5b6.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/app/layout-226f2bd71acf9f9e.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/24cf1b50-159cca90b09285e0.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/9ffa21ba-c069766d809bd4c7.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/600-9a9fcafaaa6c1c4c.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/5448-2a3cfd853d899c9a.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/8-8ca70ca619d8e099.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/app/error-4a29e9399afba038.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><script src="/_next/static/chunks/app/not-found-dd95690acf732f18.js" async="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script><meta name="next-size-adjust" content=""/><title>Grokipedia</title><meta name="description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><link rel="icon" type="image/x-icon" href="/favicon.ico" sizes="48x48"/><link rel="icon" href="/images/icon-dark.png" media="(prefers-color-scheme: light)" type="image/png"/><link rel="icon" href="/images/icon-light.png" media="(prefers-color-scheme: dark)" type="image/png"/><link rel="apple-touch-icon" href="/icon-192x192.png"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><meta property="og:title" content="Grokipedia"/><meta property="og:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta property="og:url" content="https://grokipedia.com"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en_US"/><meta property="og:type" content="website"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Grokipedia"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Grokipedia"/><meta name="twitter:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><title>Carbetocin</title><meta name="description" content="Carbetocin , sold under the brand names Pabal among others, is a medication used to prevent excessive bleeding after childbirth, particularly following Cesarean section.[2] It appears to work as well as oxytocin.[3] Due to it being less economical than other options, use is not recommended by NHS Scotland.[2] It is given by injection into a vein or muscle.[3] A heat-stable formulation is available for prevention of postpartum hemorrhage in low-resource settings without reliable cold chain.[3]..."/><meta name="author" content="system"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><link rel="canonical" href="https://grokipedia.com/page/Carbetocin"/><meta property="og:title" content="Carbetocin"/><meta property="og:description" content="Carbetocin , sold under the brand names Pabal among others, is a medication used to prevent excessive bleeding after childbirth, particularly following Cesarean section.[2] It appears to work as well as oxytocin.[3] Due to it being less economical than other options, use is not recommended by NHS Scotland.[2] It is given by injection into a vein or muscle.[3] A heat-stable formulation is available for prevention of postpartum hemorrhage in low-resource settings without reliable cold chain.[3]..."/><meta property="og:url" content="https://grokipedia.com/page/Carbetocin"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Carbetocin"/><meta property="og:type" content="article"/><meta property="article:modified_time" content="1970-01-21T09:19:13.160Z"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Carbetocin"/><meta name="twitter:description" content="Carbetocin , sold under the brand names Pabal among others, is a medication used to prevent excessive bleeding after childbirth, particularly following Cesarean section.[2] It appears to work as well as oxytocin.[3] Due to it being less economical than other options, use is not recommended by NHS Scotland.[2] It is given by injection into a vein or muscle.[3] A heat-stable formulation is available for prevention of postpartum hemorrhage in low-resource settings without reliable cold chain.[3]..."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><link rel="icon" href="/favicon.ico" type="image/x-icon" sizes="16x16"/><meta name="sentry-trace" content="fc1bea310abe1c0ac857acad78689ee8-1056210134f64666-1"/><meta name="baggage" content="sentry-environment=production,sentry-public_key=5f2258f71198ee26a355127af230c3a6,sentry-trace_id=fc1bea310abe1c0ac857acad78689ee8,sentry-org_id=4508179396558848,sentry-transaction=GET%20%2Fpage%2F%5Bslug%5D,sentry-sampled=true,sentry-sample_rand=0.32147179658309355,sentry-sample_rate=1"/><script src="/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule="" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh"></script></head><body class="flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b"><div hidden=""><!--$--><!--/$--></div><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">((a,b,c,d,e,f,g,h)=>{let i=document.documentElement,j=["light","dark"];function k(b){var c;(Array.isArray(a)?a:[a]).forEach(a=>{let c="class"===a,d=c&&f?e.map(a=>f[a]||a):e;c?(i.classList.remove(...d),i.classList.add(f&&f[b]?f[b]:b)):i.setAttribute(a,b)}),c=b,h&&j.includes(c)&&(i.style.colorScheme=c)}if(d)k(d);else try{let a=localStorage.getItem(b)||c,d=g&&"system"===a?window.matchMedia("(prefers-color-scheme: dark)").matches?"dark":"light":a;k(d)}catch(a){}})("class","theme","dark",null,["light","dark"],null,true,true)</script><header class="h-16 bg-surface-base fixed top-0 z-50 w-full"><div class="hidden h-full grid-cols-[1fr_3fr_1fr] items-center gap-4 !py-0 md:grid max-w-full py-6 px-4 w-full mx-auto"><div class="-ml-2 justify-self-start"><a class="cursor-pointer" href="/"><svg width="200" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="mx-auto flex w-full"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full px-3 shadow-none sm:w-80 focus-visible:z-1 mx-auto h-full w-full rounded-full bg-surface-l1" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div><div class="flex items-center gap-2 justify-self-end"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0" type="button" id="radix-_R_7apfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button></div></div><div class="flex h-full items-center md:hidden justify-between max-w-full py-6 px-4 w-full mx-auto pt-8"><div class="flex items-center"><div class="-ml-2"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button" aria-label="Toggle table of contents"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-list h-6 w-6"><path d="M3 12h.01"></path><path d="M3 18h.01"></path><path d="M3 6h.01"></path><path d="M8 12h13"></path><path d="M8 18h13"></path><path d="M8 6h13"></path></svg></button></div><a class="cursor-pointer" href="/"><svg width="160" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="flex items-center gap-1"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0 [&amp;_svg]:!w-5" type="button" id="radix-_R_aipfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-search h-5 w-5"><circle cx="11" cy="11" r="8"></circle><path d="m21 21-4.3-4.3"></path></svg></button></div></div></header><div class="bg-surface-base fixed right-0 top-16 z-50 h-[calc(100vh-4rem)] w-full transform border-l transition-transform duration-300 ease-in-out sm:w-1/2 md:hidden translate-x-full"><div class="flex flex-col gap-4 p-4"><div class="flex flex-row gap-2"><button class="focus-visible:ring-ring inline-flex items-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full shadow-none sm:w-80 h-10 w-full justify-start rounded-full bg-surface-l1 px-4" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div></div></div><div><div class="min-[1350px]:grid min-[1350px]:grid-cols-[1fr_3fr_1fr]"><nav class="bg-surface-base hidden h-[calc(100vh-4rem)] overflow-y-auto px-6 pb-32 min-[1350px]:sticky min-[1350px]:top-16 min-[1350px]:block scrollbar-none [-ms-overflow-style:none] [scrollbar-width:none] [&amp;::-webkit-scrollbar]:hidden [overscroll-behavior:contain] pt-8"><ul class="space-y-2 text-sm"><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#carbetocin" class="transition-opacity hover:opacity-100 opacity-50">Carbetocin</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#medical-uses" class="transition-opacity hover:opacity-100 opacity-50">Medical uses</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#comparison-with-other-medication" class="transition-opacity hover:opacity-100 opacity-50">Comparison with other medication</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#adverse-effects" class="transition-opacity hover:opacity-100 opacity-50">Adverse effects</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#interactions" class="transition-opacity hover:opacity-100 opacity-50">Interactions</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pharmacology" class="transition-opacity hover:opacity-100 opacity-50">Pharmacology</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#mechanism-of-action" class="transition-opacity hover:opacity-100 opacity-50">Mechanism of action</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pharmacokinetics" class="transition-opacity hover:opacity-100 opacity-50">Pharmacokinetics</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#society-and-culture" class="transition-opacity hover:opacity-100 opacity-50">Society and culture</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#legal-status" class="transition-opacity hover:opacity-100 opacity-50">Legal status</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#brand-names" class="transition-opacity hover:opacity-100 opacity-50">Brand names</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#references" class="transition-opacity hover:opacity-100 opacity-50">References</a></li></ul></nav><div class="relative top-16 pb-32 pt-8 px-4 md:px-8"><div class="mx-auto max-w-[850px]"><button data-state="closed" type="button" class="flex items-center"><div class="text-fg-tertiary mb-2 flex cursor-help items-center gap-2 text-sm"><span class="inline-flex items-center justify-center p-0 m-0" data-namespace="@xai/icons" data-slot="icon" style="height:16px;width:16px"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 33 33" aria-hidden="true" class="" focusable="false" style="fill:currentColor;height:16px;width:16px"><path fill="currentColor" d="m13.237 21.04 11.082-8.19c.543-.4 1.32-.244 1.578.38 1.363 3.288.754 7.241-1.957 9.955-2.71 2.714-6.482 3.31-9.93 1.954l-3.765 1.745c5.401 3.697 11.96 2.782 16.059-1.324 3.251-3.255 4.258-7.692 3.317-11.693l.008.009c-1.365-5.878.336-8.227 3.82-13.031q.123-.17.247-.345l-4.585 4.59v-.014L13.234 21.044M10.95 23.031c-3.877-3.707-3.208-9.446.1-12.755 2.446-2.449 6.454-3.448 9.952-1.979L24.76 6.56c-.677-.49-1.545-1.017-2.54-1.387A12.465 12.465 0 0 0 8.675 7.901c-3.519 3.523-4.625 8.94-2.725 13.561 1.42 3.454-.907 5.898-3.251 8.364-.83.874-1.664 1.749-2.335 2.674l10.583-9.466"></path></svg></span><span>Fact-checked by Grok<!-- --> <!-- -->4 days ago</span></div></button><article class="text-[16px]"><h1 id="carbetocin" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Carbetocin<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>





























































































<!-- -->
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Carbetocin</strong> , sold under the brand names <strong>Pabal</strong> among others, is a medication used to prevent <span class="inline text-[1em] leading-7">excessive bleeding after childbirth</span>, particularly following <span class="inline text-[1em] leading-7">Cesarean section</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4habav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> It appears to work as well as <span class="inline text-[1em] leading-7">oxytocin</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6habav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> Due to it being less economical than other options, use is not recommended by <span class="inline text-[1em] leading-7">NHS Scotland</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8habav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> It is given by <span class="inline text-[1em] leading-7">injection into a vein</span> or <span class="inline text-[1em] leading-7">muscle</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bhabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> A heat-stable formulation is available for prevention of postpartum hemorrhage in low-resource settings without reliable cold chain.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_chabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Side effects differ little from that of no treatment or <span class="inline text-[1em] leading-7">placebo</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_21qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> Use is not recommended in people with <span class="inline text-[1em] leading-7">epilepsy</span> or <span class="inline text-[1em] leading-7">eclampsia</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_51qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Carbetocin is a manufactured long acting <span class="inline text-[1em] leading-7">form</span> of <span class="inline text-[1em] leading-7">oxytocin</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_81qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> It works by activating the <span class="inline text-[1em] leading-7">oxytocin receptor</span> which causes the <span class="inline text-[1em] leading-7">uterus</span> to contract.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bhqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Carbetocin was first described in 1974.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_12abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> It was approved for medical use in Canada and the United Kingdom in 1997.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_22abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> It is on the <span class="inline text-[1em] leading-7">World Health Organization&#x27;s List of Essential Medicines</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_42abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> It is not available in the United States or Japan.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_52abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup></span>
<h2 id="medical-uses" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Medical uses<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Carbetocin has been approved for use immediately following an elective <span class="inline text-[1em] leading-7">Cesarean section</span> when a local or spinal <span class="inline text-[1em] leading-7">anesthesia</span> has been used.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_33abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup> Since the uterus cannot contract on its own following incision during a Cesarean section, exogenous administration of oxytocin or an analog is necessary to restore uterine tone and prevent hemorrhage.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_43abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4jabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Safety of carbetocin following vaginal births and emergency Cesarean sections has not been established, though studies have suggested efficacy following vaginal births to that following Cesarean sections. Some studies have shown that a 10-70 ug dose following vaginal delivery caused contractions and no adverse side effects.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_13qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup> Carbetocin has also been shown to increase uterine involution (the return of the uterus to its contracted state after the birth of the baby) in humans, horses and cows.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_23qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup></span>
<h3 id="comparison-with-other-medication" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Comparison with other medication<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">In 2018, heat-stable carbetocin, a <span class="inline text-[1em] leading-7">formulation</span> that does not require strict refrigeration, was found to be <span class="inline text-[1em] leading-7">as good as</span> oxytocin for reduction of postpartum hemorrhage after vaginal delivery.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_34qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup> Heat-stable carbetocin was prequalified by WHO in 2019 and, as of 2024, has market authorization in 19 countries for PPH prevention after vaginal birth.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_44qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup> It is hoped that this will make oxytocic hemorrhage control more widely available and less expensive,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_54qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup> which will be particularly useful in regions of <span class="inline text-[1em] leading-7">developing countries</span> where the <span class="inline text-[1em] leading-7">cold chain</span> (in drug transport and storage) is unreliable because of power outages or equipment problems.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_84qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Due to carbetocin&#x27;s considerably longer half-life, its effects are longer lasting than other oxytocin homologs such as <span class="inline text-[1em] leading-7">oxytocin</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_25abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup> Studies have shown that a single carbetocin dose requires less additional uterotonic therapy than an oxytocin infusion following a Cesarean section.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_35abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup> Oxytocin receptor antagonists, such as barusiban or <span class="inline text-[1em] leading-7">atosiban</span> have the opposite effect of depressing oxytocin receptor activity and can be used to stop premature labor and uterine contractions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_55abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup></span>
<h2 id="adverse-effects" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Adverse effects<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Frequent adverse effects (10â€“40% or greater in some clinical trials) include nausea, vomiting, abdominal pain, itching (pruritus), flushing, feeling of warmth, headache, and trembling (tremor). Infrequent adverse effects (1â€“5%) include back pain, chest pain, dizziness, chills, sweating, metallic taste, tachycardia, and respiratory distress (dyspnoea); anaemia may also occur but is often related to the procedure. Clinical trials indicate that the adverse effects of carbetocin are similar in type and frequency to those of oxytocin and often comparable to placebo.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_16abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1mabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Contraindications for the use of carbetocin include administration prior to delivery of the infant (e.g., to induce labor) or hypersensitivity to carbetocin or oxytocin. Carbetocin is also contraindicated in patients with cardiovascular disease (e.g., coronary artery disease, valvular heart disease, cardiomyopathy, heart failure); use with caution in those with hypertension or preeclampsia. Overdosage of carbetocin may be associated with uterine hyperactivity and pain. Signs of overdose may arise from water intoxication and hyponatremia, especially with excessive fluid intake. Treatment consists of the administration of a dilute solution of ethanol, diuretics, supportive therapy, and symptomatic treatment of hyponatremia if needed.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_16qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup></span>
<h2 id="interactions" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Interactions<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">No specific drug interactions have been reported with carbetocin in clinical studies. However, as an analogue of oxytocin, it may interact similarly to oxytocin. For example, carbetocin may potentiate the effects of vasoconstrictor agents (e.g., leading to hypertension when used with caudal block anesthesia) or prostaglandins such as dinoprostone and misoprostol, which can increase uterine contractions. Concurrent use with other uterotonics like oxytocin or methylergometrine may result in cumulative effects. Careful monitoring is recommended if co-administered postpartum.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_17qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Carbetocin has greater selectivity for oxytocin receptors compared to vasopressin receptors V1a (vascular/uterine) and V2 (renal), with much lower binding affinity, reducing the likelihood of significant interactions with vasopressin pathways.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_18abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup></span>
<h1 id="pharmacology" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Pharmacology<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<h3 id="mechanism-of-action" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Mechanism of action<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Carbetocin works as an <span class="inline text-[1em] leading-7">oxytocic</span>, <span class="inline text-[1em] leading-7">antihemorrhagic</span> and <span class="inline text-[1em] leading-7">uterotonic</span> drug in the peripheral nervous system. The most common causes of <span class="inline text-[1em] leading-7">postpartum hemorrhage</span> are lack of tone in the uterus from overstretching or the use of an anesthetic.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_59qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Carbetocin functions as an agonist at peripheral <span class="inline text-[1em] leading-7">oxytocin receptors</span>, particularly in the myometrium. Oxytocin receptors are G protein-coupled<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup> and their mechanism of action involves second messengers and the production of inositol phosphates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup> Carbetocin mimics this mechanism.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup> Binding for carbetocin and other oxytocin agonists has been shown to be nonselective at the extracellular N-terminus and loops E2 and E3.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup> The oxytocin receptor shows similar affinity for oxytocin and carbetocin; clinically, carbetocin is as effective as oxytocin in preventing postpartum hemorrhage.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6aabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup> Carbetocin has a much longer lasting effect than oxytocin, necessitating only a single dose. Carbetocin is a <span class="inline text-[1em] leading-7">biased agonist</span> of the oxytocin receptor.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[25]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">During pregnancy, the synthesis of oxytocin receptors in the uterus greatly increases, reaching a peak during labor and delivery. Consequently, the administration of carbetocin or another oxytocin analog during or immediately following birth will have increased uterotonic and contractile effect. The application of carbetocin does not affect a non-pregnant uterus with lower oxytocin receptor expression.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> Carbetocin should not be used to induce or augment labor since it could cause cardiac or respiratory distress to mother or infant.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup></span>
<h3 id="pharmacokinetics" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Pharmacokinetics<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Carbetocin is to be used in the hospital by prescription only. It can be administered intravenously or intramuscularly. In both cases, the recommended dose for an average adult female is 100 micrograms. Contractile effects of the uterus are apparent within two minutes and can be observed for approximately one hour,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> though maximum binding occurs about 30 minutes after intramuscular injection. Administration is performed immediately following parturition to minimize risk of postpartum hemorrhage by inducing uterine contractions, increasing muscle tone. If further uterine stimulation is needed, treatment with other forms of <span class="inline text-[1em] leading-7">oxytocic</span> <span class="inline text-[1em] leading-7">uterotonic</span> drugs should be used.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> A heat-stable formulation of carbetocin is available, which maintains efficacy without refrigeration requirements.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Endogenous and synthetic oxytocin has a half-life of approximately 3.5 minutes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup> Carbetocin, in comparison, has a much longer half-life of approximately 40 minutes following intravenous administration (or 44-55 minutes intramuscular).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup> The bioavailable dose is around 80%.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup> The elimination half-life following intravenous administration is around 40 minutes, though the elimination mechanism is not entirely known.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> Studies have shown that elimination is only minimally renal (0.7%), but may occur at least partially through enzymatic degradation of peptides, primarily on the C-terminal end.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup> Both elimination and volume of distribution are not dose dependent.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup></span>
<h2 id="society-and-culture" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Society and culture<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="legal-status" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Legal status<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Carbetocin is approved in more than 80 countries worldwide, excluding the United States and Japan. <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup> It is marketed under brand names such as Duratocin, Pabal, and Lonactene. A heat-stable formulation of carbetocin, suitable for use in low- and middle-income countries without cold chain requirements, has been approved in additional countries including India (2021), South Sudan, Sierra Leone, and is under registration in others as of 2024. <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_3dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup> Duratocin is also approved for veterinary use in several European countries, including Poland, Germany, Italy, Belgium, Luxembourg, France, and the Netherlands. <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup></span>
<h3 id="brand-names" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Brand names<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Duratocin, Pabal, Lonactene (human use); Depotocin, Comoton, Decomoton (historical or veterinary).</span></article><div id="references" class="min-w-0 scroll-mt-8 overflow-hidden"><div class="text-[16px]"><h2 id="references" node="[object Object]" class="mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden">References</h2></div><ol class="columns-1 gap-x-12 [counter-reset:item] md:columns-2"><li id="https://go.drugbank.com/drugs/DB01282" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://go.drugbank.com/drugs/DB01282" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://go.drugbank.com/drugs/DB01282</a></span></div></li><li id="2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><em>British National Formulary: BNF 76</em> (76th ed.). Pharmaceutical Press. 2018. p. 804. <span class="inline text-[1em] leading-7">ISBN</span> 978-0-85711-338-2.</span></div></li><li id="3" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.who.int/selection_medicines/committees/expert/22/applications/s22.1_carbetocin.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Proposal for Inclusion of Carbetocin in the Who List of Essential Medicines&quot;</a> (PDF). <em>WHO</em>. Retrieved 25 October 2019.</span></div></li><li id="4" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Morton IK, Hall JM (2012). <a href="https://books.google.com/books?id=tsjrCAAAQBAJ&amp;pg=PA65" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>Concise Dictionary of Pharmacological Agents: Properties and Synonyms</em></a>. Springer Science &amp; Business Media. pp. 65â€“. <span class="inline text-[1em] leading-7">ISBN</span> 978-94-011-4439-1.</span></div></li><li id="5" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Elks J (2014). <a href="https://books.google.com/books?id=0vXTBwAAQBAJ&amp;pg=PA214" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies</em></a>. Springer. pp. 214â€“. <span class="inline text-[1em] leading-7">ISBN</span> 978-1-4757-2085-3.</span></div></li><li id="6" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">World Health Organization</span> (2019). <em>World Health Organization model list of essential medicines: 21st list 2019</em>. Geneva: World Health Organization. <span class="inline text-[1em] leading-7">hdl</span>:<a href="https://hdl.handle.net/10665%2F325771" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10665/325771</a>. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.</span></div></li><li id="7" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://web.archive.org/web/20201128074038/https://www.drugs.com/mmx/carbetocin.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Carbetocin Drug Information, Professional&quot;</a>. <em>Drugs.com</em>. Archived from <a href="https://www.drugs.com/mmx/carbetocin.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 28 November 2020. Retrieved 12 November 2019.</span></div></li><li id="8" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Attilakos G, Psaroudakis D, Ash J, Buchanan R, Winter C, Donald F, et al. (July 2010). &quot;Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial&quot;. <em>BJOG</em>. <strong>117</strong> (8): 929â€“936. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1111%2Fj.1471-0528.2010.02585.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1111/j.1471-0528.2010.02585.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/20482535" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20482535</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:205616218" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">205616218</a>.</span></div></li><li id="9" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Moertl MG, Friedrich S, Kraschl J, Wadsack C, Lang U, Schlembach D (October 2011). <a href="https://doi.org/10.1111%2Fj.1471-0528.2011.03022.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Haemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomised trial&quot;</a>. <em>BJOG</em>. <strong>118</strong> (11): 1349â€“1356. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1111%2Fj.1471-0528.2011.03022.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1111/j.1471-0528.2011.03022.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/21668768" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21668768</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:41172212" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">41172212</a>.</span></div></li><li id="https://www.tga.gov.au/sites/default/files/auspar-carbetocin-180823-cer.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.tga.gov.au/sites/default/files/auspar-carbetocin-180823-cer.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.tga.gov.au/sites/default/files/auspar-carbetocin-180823-cer.pdf</a></span></div></li><li id="11" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Bajcsy AC, Szenci O, van der Weijden GC, Doornenbal A, Maassen F, Bartyik J, Taverne MA (January 2006). &quot;The effect of a single oxytocin or carbetocin treatment on uterine contractility in early postpartum dairy cows&quot;. <em>Theriogenology</em>. <strong>65</strong> (2): 400â€“414. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.theriogenology.2005.05.040" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.theriogenology.2005.05.040</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15993938" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15993938</a>.</span></div></li><li id="12" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Schramme AR, Pinto CR, Davis J, Whisnant CS, Whitacre MD (November 2008). &quot;Pharmacokinetics of carbetocin, a long-acting oxytocin analogue, following intravenous administration in horses&quot;. <em>Equine Veterinary Journal</em>. <strong>40</strong> (7): 658â€“661. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.2746%2F042516408X334343" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.2746/042516408X334343</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/19165935" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">19165935</a>.</span></div></li><li id="13" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Widmer M, Piaggio G, Nguyen TM, Osoti A, Owa OO, Misra S, et al. (August 2018). <a href="https://doi.org/10.1056%2FNEJMoa1805489" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Heat-Stable Carbetocin versus Oxytocin to Prevent Hemorrhage after Vaginal Birth&quot;</a>. <em>The New England Journal of Medicine</em>. <strong>379</strong> (8): 743â€“752. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1056%2FNEJMoa1805489" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1056/NEJMoa1805489</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/29949473" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">29949473</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:205103322" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">205103322</a>.</span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC12458669/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12458669/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC12458669/</a></span></div></li><li id="14" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Malm M, Madsen I, KjellstrÃ¶m J (June 2018). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001700" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Development and stability of a heat-stable formulation of carbetocin for the prevention of postpartum haemorrhage for use in low and middle-income countries&quot;</a>. <em>Journal of Peptide Science</em>. <strong>24</strong> (6) e3082. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Fpsc.3082" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/psc.3082</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001700" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6001700</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/29700898" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">29700898</a>.</span></div></li><li id="15" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Mundasad S (28 June 2018). <a href="https://www.bbc.com/news/world-asia-44617525" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Revamped drug could save lives of many new mothers: WHO&quot;</a>. BBC News. Retrieved 28 June 2018.</span></div></li><li id="16" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Gimpl G, Postina R, Fahrenholz F, Reinheimer T (March 2005). &quot;Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin&quot;. <em>European Journal of Pharmacology</em>. <strong>510</strong> (1â€“2): 9â€“16. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.ejphar.2005.01.010" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.ejphar.2005.01.010</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/15740719" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">15740719</a>.</span></div></li><li id="https://www.tga.gov.au/sites/default/files/auspar-carbetocin-180823-pi.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.tga.gov.au/sites/default/files/auspar-carbetocin-180823-pi.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.tga.gov.au/sites/default/files/auspar-carbetocin-180823-pi.pdf</a></span></div></li><li id="https://www.drugs.com/international/carbetocin.html" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.drugs.com/international/carbetocin.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.drugs.com/international/carbetocin.html</a></span></div></li><li id="https://www.ferring.ca/media/1368/duratocin-vial-pm-control-no-284214-en-22jul2024.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ferring.ca/media/1368/duratocin-vial-pm-control-no-284214-en-22jul2024.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ferring.ca/media/1368/duratocin-vial-pm-control-no-284214-en-22jul2024.pdf</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC5021139/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5021139/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC5021139/</a></span></div></li><li id="20" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://web.archive.org/web/20120525031943/http://www.ferring.com/en/therapeutic/Reproductive_Health/Products/Obstetrics+Products.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Therapeutic Areas - Reproductive Health&quot;</a>. <em>Ferring Pharmaceuticals</em>. Archived from <a href="http://ferring.com/en/therapeutic/Reproductive_Health/Products/Obstetrics+Products.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">the original</a> on 25 May 2012. Retrieved 5 June 2012.</span></div></li><li id="21" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Gimpl G, Fahrenholz F (April 2001). &quot;The oxytocin receptor system: structure, function, and regulation&quot;. <em>Physiological Reviews</em>. <strong>81</strong> (2): 629â€“683. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1152%2Fphysrev.2001.81.2.629" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1152/physrev.2001.81.2.629</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/11274341" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11274341</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:13265083" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">13265083</a>.</span></div></li><li id="22" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">EngstrÃ¸m T, Barth T, Melin P, Vilhardt H (August 1998). &quot;Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation&quot;. <em>European Journal of Pharmacology</em>. <strong>355</strong> (2â€“3): 203â€“210. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2FS0014-2999%2898%2900513-5" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/S0014-2999(98)00513-5</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9760035" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9760035</a>.</span></div></li><li id="23" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Gulliver D, Werry E, Reekie TA, Katte TA, Jorgensen W, Kassiou M (January 2019). <a href="https://unsworks.unsw.edu.au/bitstreams/547ad575-bc60-4b4e-8bd3-681eff7ee47e/download" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Targeting the Oxytocin System: New Pharmacotherapeutic Approaches&quot;</a>. <em>Trends in Pharmacological Sciences</em>. <strong>40</strong> (1): 22â€“37. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.tips.2018.11.001" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.tips.2018.11.001</a>. <span class="inline text-[1em] leading-7">hdl</span>:<a href="https://hdl.handle.net/1959.4%2Funsworks_81554" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1959.4/unsworks_81554</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/30509888" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">30509888</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:54559394" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">54559394</a>.</span></div></li><li id="17" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://web.archive.org/web/20111115071733/http://secure.healthlinks.net.au/content/ferring/pi.cfm?product=fppdurai11007" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Product Information - Duratocin&quot;</a>. <em>healthlinks.net</em>. Archived from the original on 15 November 2011. Retrieved 5 June 2012.</span></div></li><li id="https://www.who.int/news/item/05-10-2025-global-health-agencies-issue-new-recommendations-to-help-end-deaths-from-postpartum-haemorrhage" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.who.int/news/item/05-10-2025-global-health-agencies-issue-new-recommendations-to-help-end-deaths-from-postpartum-haemorrhage" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.who.int/news/item/05-10-2025-global-health-agencies-issue-new-recommendations-to-help-end-deaths-from-postpartum-haemorrhage</a></span></div></li><li id="10" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Silcox J, Schulz P, Horbay GL, Wassenaar W (September 1993). &quot;Transfer of carbetocin into human breast milk&quot;. <em>Obstetrics and Gynecology</em>. <strong>82</strong> (3): 456â€“459. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/8355953" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">8355953</a>.</span></div></li><li id="https://list.essentialmeds.org/recommendations/906" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://list.essentialmeds.org/recommendations/906" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://list.essentialmeds.org/recommendations/906</a></span></div></li><li id="https://www.biospace.com/women-in-india-are-the-first-in-the-world-to-receive-new-heat-stable-carbetocin-formulation-to-prevent-excessive-bleeding-after-childbirth" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.biospace.com/women-in-india-are-the-first-in-the-world-to-receive-new-heat-stable-carbetocin-formulation-to-prevent-excessive-bleeding-after-childbirth" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.biospace.com/women-in-india-are-the-first-in-the-world-to-receive-new-heat-stable-carbetocin-formulation-to-prevent-excessive-bleeding-after-childbirth</a></span></div></li></ol></div><div class="text-fg-secondary text-xs [&amp;_*]:mb-2"><hr class="border-border-l1 my-8 rounded-sm border-t"/>
<span class="mb-4 block break-words text-[1em] leading-7">The content is adapted from <a href="https://en.wikipedia.org/wiki/Carbetocin" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Wikipedia</a>, licensed under Creative Commons Attribution-ShareAlike 4.0 License.</span></div></div></div><div class="hidden min-[1400px]:block"></div></div></div><!--$--><!--/$--><div role="region" aria-label="Notifications (F8)" tabindex="-1" style="pointer-events:none"><ol tabindex="-1" class="pointer-events-none fixed top-0 z-[100] flex max-h-screen w-full flex-col-reverse p-4 max-sm:left-0 sm:bottom-0 sm:right-0 sm:top-auto sm:max-w-[420px] sm:flex-col pl-16 pr-2 pt-16 sm:px-4"></ol></div><script type="application/json" id="server-client-data-experimentation">{"status":"uninitialized"}</script><script src="/_next/static/chunks/webpack-e121ed42680f327e.js" nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh" id="_R_" async=""></script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">(self.__next_f=self.__next_f||[]).push([0])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"1:\"$Sreact.fragment\"\n3:I[91363,[],\"\"]\n4:I[23775,[],\"\"]\n5:I[57654,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"PageHeaderProvider\"]\n6:I[17618,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"HeaderContent\"]\n7:I[25529,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"6751\",\"static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js\"],\"default\"]\n9:I[6666,[],\"OutletBoundary\"]\nb:I[80415,[],\"AsyncMetadataOutlet\"]\nd:I[6666,[],\"ViewportBoundary\"]\nf:I[6666,[],\"MetadataBoundary\"]\n10:\"$Sreact.suspense\"\n12:I[95909,[\"4219\",\"static/chunks/app/global-error-4d07d20223cd4b4c.js\"],\"default\"]\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"13:I[51498,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"ConstantsProvider\"]\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"14:I[91073,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"15:I[38642,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"16:I[99648,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"17:I[78825,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"18:I[8550,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MixpanelProvider\"]\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"19:I[12290,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MobileTocProvider\"]\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"1a:I[53947,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"NuqsAdapter\"]\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"1b:I[91873,[\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8039\",\"static/chunks/app/error-4a29e9399afba038.js\"],\"default\"]\n1c:I[5091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"4345\",\"static/chunks/app/not-found-dd95690acf732f18.js\"],\"default\"]\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"1d:I[16091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,":HL[\"/_next/static/media/1f2316909698f815.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/3d4419af2cf8609b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/4dec29efcaeb336c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/74452ea3ef0f9101.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/904ef0a86fe32a00.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/d886a03bcda7ad8f.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/e1447589d6f59c4b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/f5a90156f8995c8c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/css/62c4caba71dfda84.css\",\"style\",{\"nonce\":\"MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh\"}]\n:HL[\"/_next/static/css/eb3d87f98fe1565f.css\",\"style\",{\"nonce\":\"MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh\"}]\n:HL[\"/_next/static/css/1b5e561215938d4d.css\",\"style\",{\"nonce\":\"MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh\"}]\n:HL[\"/_next/static/css/0227d069a630d414.css\",\"style\",{\"nonce\":\"MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh\"}]\n:HL[\"/_next/static/css/f87fff2ab93d05a7.css\",\"style\",{\"nonce\":\"MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh\"}]\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"0:{\"P\":null,\"b\":\"BpM29AX4fmgcUxZ_6t0le\",\"p\":\"\",\"c\":[\"\",\"page\",\"Carbetocin\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"page\",{\"children\":[[\"slug\",\"Carbetocin\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/62c4caba71dfda84.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/eb3d87f98fe1565f.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh\"}],[\"$\",\"link\",\"2\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/1b5e561215938d4d.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh\"}],[\"$\",\"link\",\"3\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/0227d069a630d414.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh\"}]],\"$L2\"]}],{\"children\":[\"page\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"slug\",\"Carbetocin\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L5\",null,{\"children\":[[\"$\",\"$L6\",null,{\"maxWidth\":\"full\",\"mobileOptions\":{\"right\":{\"showFixedIssues\":true,\"showThemeSwitcher\":true,\"showSearch\":true,\"showTableOfContents\":true}}}],[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L7\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$L8\",[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/f87fff2ab93d05a7.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh\"}]],[\"$\",\"$L9\",null,{\"children\":[\"$La\",[\"$\",\"$Lb\",null,{\"promise\":\"$@c\"}]]}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[[\"$\",\"$Ld\",null,{\"children\":\"$Le\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]],[\"$\",\"$Lf\",null,{\"children\":[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$10\",null,{\"fallback\":null,\"children\":\"$L11\"}]}]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$12\",[]],\"s\":false,\"S\":false}\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"2:[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"bg-surface-base antialiased\",\"suppressHydrationWarning\":true,\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"title\",null,{\"children\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"type\":\"image/x-icon\",\"href\":\"/favicon.ico\",\"sizes\":\"48x48\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-dark.png\",\"media\":\"(prefers-color-scheme: light)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-light.png\",\"media\":\"(prefers-color-scheme: dark)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"apple-touch-icon\",\"href\":\"/icon-192x192.png\"}],[\"$\",\"link\",null,{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\"}],[\"$\",\"meta\",null,{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",null,{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"meta\",null,{\"property\":\"og:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"property\":\"og:url\",\"content\":\"https://grokipedia.com\"}],[\"$\",\"meta\",null,{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:locale\",\"content\":\"en_US\"}],[\"$\",\"meta\",null,{\"property\":\"og:type\",\"content\":\"website\"}],[\"$\",\"meta\",null,{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:alt\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}]]}],[\"$\",\"body\",null,{\"className\":\"flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b\",\"children\":[[\"$\",\"$L13\",null,{\"children\":[\"$\",\"$L14\",null,{\"children\":[\"$\",\"$L15\",null,{\"defaultTheme\":\"dark\",\"nonce\":\"MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh\",\"children\":[\"$\",\"$L16\",null,{\"children\":[\"$\",\"$L17\",null,{\"children\":[\"$\",\"$L18\",null,{\"children\":[\"$\",\"$L19\",null,{\"children\":[\"$\",\"$L1a\",null,{\"children\":[[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$1b\",\"errorStyles\":[],\"errorScripts\":[],\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L1c\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}],[\"$\",\"$L1d\",null,{}]]}]}]}]}]}]}]}]}],[\"$\",\"script\",null,{\"type\":\"application/json\",\"id\":\"server-client-data-experimentation\",\"children\":\"{\\\"status\\\":\\\"uninitialized\\\"}\"}]]}]]}]\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"e:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1, interactive-widget=resizes-content\"}]]\na:null\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"1e:I[42712,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"HydrationBoundary\"]\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"21:I[6367,[],\"IconMark\"]\n1f:T36aa,"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"# Carbetocin\n\n| **Attribute** | **Details** |\n|---------------|-------------|\n| **Trade names** | Duratocin, Pabal, Lonactene, others |\n| **Other names** | (2-O-Methyltyrosine)deamino-1-carbaoxytocin; Deamino-2-O-methyltyrosine-1-carbaoxytocin; 1-Butanoic acid-2-(O-methy-L-tyrosine)-1-carbaoxytocin; 1-butyric acid-2-[3-(4-methoxyphenyl)-L-alanine]oxytocin |\n| **AHFS/Drugs.com** | [Micromedex Detailed Consumer Information](https://www.drugs.com/cons/carbetocin.html) |\n| **Routes of administration** | [Intravenous](Intravenous_therapy \"Intravenous therapy\"), [intramuscular](Intramuscular_injection \"Intramuscular injection\") |\n| **ATC code** | - [H01BB03](ATC_code_H01 \"ATC code H01\") ([WHO](https://www.whocc.no/atc_ddd_index/?code=H01BB03)) |\n| **Legal status** | - UK: [POM](Prescription_drug \"Prescription drug\") (Prescription only) |\n| **Bioavailability** | 80% ([IM](Intramuscular_injection \"Intramuscular injection\")) |\n| **Elimination half-life** | 40 minutes (IV)[](https://go.drugbank.com/drugs/DB01282) |\n| **IUPAC name** | (2 *S*)-1-[(3 *S* ,6 *S* ,9 *S* ,12 *S* ,15 *S*)-12-[(2 *S*)-butan-2-yl]-9-(2-carbamoylethyl)-6-(carbamoylmethyl)-15-[(4-hydroxyphenyl)methyl]-16-methyl-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentazacycloicosane-3-carbonyl]-_N_ -[(1 *S*)-1-(carbamoylmethylcarbamoyl)-3-methyl-butyl]pyrrolidine-2-carboxamide |\n| **CAS Number** | - [37025-55-1](https://commonchemistry.cas.org/detail?cas_rn=37025-55-1) |\n| **PubChem CID** | - [16681432](https://pubchem.ncbi.nlm.nih.gov/compound/16681432) |\n| **DrugBank** | - [DB01282](https://www.drugbank.ca/drugs/DB01282) |\n| **ChemSpider** | - [16736854](https://www.chemspider.com/Chemical-Structure.16736854.html) |\n| **UNII** | - [88TWF8015Y](https://precision.fda.gov/uniisearch/srs/unii/88TWF8015Y) |\n| **KEGG** | - [D07229](https://www.kegg.jp/entry/D07229) |\n| **CompTox Dashboard (EPA)** | - [DTXSID90897527](https://comptox.epa.gov/dashboard/chemical/details/DTXSID90897527) |\n| **ECHA InfoCard** | [100.048.450](https://echa.europa.eu/substance-information/-/substanceinfo/100.048.450) |\n| **Formula** | C45H69N11O12S |\n| **Molar mass** | 988.17 gÂ·molâˆ’1 |\n| **SMILES** | CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSCCCC(=O)N[C@H](C(=O)N1)Cc2ccc(cc2)OC)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N |\n| **InChI** | InChI=1S/C45H69N11O12S/c1-6-25(4)38-44(66)51-28(15-16-34(46)57)40(62)52-31(21-35(47)58)41(63)54-32(23-69-18-8-10-37(60)50-30(42(64)55-38)20-26-11-13-27(68-5)14-12-26)45(67)56-17-7-9-33(56)43(65)53-29(19-24(2)3)39(61)49-22-36(48)59/h11-14,24-25,28-33,38H,6-10,15-23H2,1-5H3,(H2,46,57)(H2,47,58)(H2,48,59)(H,49,61)(H,50,60)(H,51,66)(H,52,62)(H,53,65)(H,54,63)(H,55,64)/t25-,28-,29-,30-,31-,32-,33-,38-/m0/s1 \u003cbr\u003e Key:NSTRIRCPWQHTIA-DTRKZRJBSA-N |\n\n**Carbetocin** , sold under the brand names **Pabal** among others, is a medication used to prevent [excessive bleeding after childbirth](Postpartum_hemorrhage \"Postpartum hemorrhage\"), particularly following [Cesarean section](Cesarean_section \"Cesarean section\").[2] It appears to work as well as [oxytocin](Oxytocin \"Oxytocin\").[3] Due to it being less economical than other options, use is not recommended by [NHS Scotland](NHS_Scotland \"NHS Scotland\").[2] It is given by [injection into a vein](Injection_into_a_vein \"Injection into a vein\") or [muscle](Intramuscular_injection \"Intramuscular injection\").[3] A heat-stable formulation is available for prevention of postpartum hemorrhage in low-resource settings without reliable cold chain.[3]\n\nSide effects differ little from that of no treatment or [placebo](Placebo \"Placebo\").[3] Use is not recommended in people with [epilepsy](Epilepsy \"Epilepsy\") or [eclampsia](Eclampsia \"Eclampsia\").[2] Carbetocin is a manufactured long acting [form](Analog_\\(chemistry\\) \"Analog \\(chemistry\\)\") of [oxytocin](Oxytocin \"Oxytocin\").[3] It works by activating the [oxytocin receptor](Oxytocin_receptor \"Oxytocin receptor\") which causes the [uterus](Uterus \"Uterus\") to contract.[4][3]\n\nCarbetocin was first described in 1974.[5] It was approved for medical use in Canada and the United Kingdom in 1997.[3] It is on the [World Health Organization's List of Essential Medicines](WHO_Model_List_of_Essential_Medicines \"WHO Model List of Essential Medicines\").[6] It is not available in the United States or Japan.[7][3]\n## Medical uses\n\nCarbetocin has been approved for use immediately following an elective [Cesarean section](Cesarean_section \"Cesarean section\") when a local or spinal [anesthesia](Anesthesia \"Anesthesia\") has been used.[8] Since the uterus cannot contract on its own following incision during a Cesarean section, exogenous administration of oxytocin or an analog is necessary to restore uterine tone and prevent hemorrhage.[8][9]\n\nSafety of carbetocin following vaginal births and emergency Cesarean sections has not been established, though studies have suggested efficacy following vaginal births to that following Cesarean sections. Some studies have shown that a 10-70 ug dose following vaginal delivery caused contractions and no adverse side effects.[](https://www.tga.gov.au/sites/default/files/auspar-carbetocin-180823-cer.pdf) Carbetocin has also been shown to increase uterine involution (the return of the uterus to its contracted state after the birth of the baby) in humans, horses and cows.[11][12]\n\n### Comparison with other medication\n\nIn 2018, heat-stable carbetocin, a [formulation](Dosage_form \"Dosage form\") that does not require strict refrigeration, was found to be [as good as](Randomized_controlled_trial#By_hypothesis_\\(superiority_vs._noninferiority_vs._equivalence\\) \"Randomized controlled trial\") oxytocin for reduction of postpartum hemorrhage after vaginal delivery.[13] Heat-stable carbetocin was prequalified by WHO in 2019 and, as of 2024, has market authorization in 19 countries for PPH prevention after vaginal birth.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12458669/) It is hoped that this will make oxytocic hemorrhage control more widely available and less expensive,[13] which will be particularly useful in regions of [developing countries](Developing_country \"Developing country\") where the [cold chain](Cold_chain \"Cold chain\") (in drug transport and storage) is unreliable because of power outages or equipment problems.[14][15]\n\nDue to carbetocin's considerably longer half-life, its effects are longer lasting than other oxytocin homologs such as [oxytocin](Oxytocin_\\(medication\\) \"Oxytocin \\(medication\\)\").[16] Studies have shown that a single carbetocin dose requires less additional uterotonic therapy than an oxytocin infusion following a Cesarean section.[8] Oxytocin receptor antagonists, such as barusiban or [atosiban](Atosiban \"Atosiban\") have the opposite effect of depressing oxytocin receptor activity and can be used to stop premature labor and uterine contractions.[16]\n## Adverse effects\n\nFrequent adverse effects (10â€“40% or greater in some clinical trials) include nausea, vomiting, abdominal pain, itching (pruritus), flushing, feeling of warmth, headache, and trembling (tremor). Infrequent adverse effects (1â€“5%) include back pain, chest pain, dizziness, chills, sweating, metallic taste, tachycardia, and respiratory distress (dyspnoea); anaemia may also occur but is often related to the procedure. Clinical trials indicate that the adverse effects of carbetocin are similar in type and frequency to those of oxytocin and often comparable to placebo.[](https://www.tga.gov.au/sites/default/files/auspar-carbetocin-180823-pi.pdf)[](https://www.drugs.com/international/carbetocin.html)\n\nContraindications for the use of carbetocin include administration prior to delivery of the infant (e.g., to induce labor) or hypersensitivity to carbetocin or oxytocin. Carbetocin is also contraindicated in patients with cardiovascular disease (e.g., coronary artery disease, valvular heart disease, cardiomyopathy, heart failure); use with caution in those with hypertension or preeclampsia. Overdosage of carbetocin may be associated with uterine hyperactivity and pain. Signs of overdose may arise from water intoxication and hyponatremia, especially with excessive fluid intake. Treatment consists of the administration of a dilute solution of ethanol, diuretics, supportive therapy, and symptomatic treatment of hyponatremia if needed.[](https://www.tga.gov.au/sites/default/files/auspar-carbetocin-180823-pi.pdf)\n## Interactions\n\nNo specific drug interactions have been reported with carbetocin in clinical studies. However, as an analogue of oxytocin, it may interact similarly to oxytocin. For example, carbetocin may potentiate the effects of vasoconstrictor agents (e.g., leading to hypertension when used with caudal block anesthesia) or prostaglandins such as dinoprostone and misoprostol, which can increase uterine contractions. Concurrent use with other uterotonics like oxytocin or methylergometrine may result in cumulative effects. Careful monitoring is recommended if co-administered postpartum.[](https://www.ferring.ca/media/1368/duratocin-vial-pm-control-no-284214-en-22jul2024.pdf)\n\nCarbetocin has greater selectivity for oxytocin receptors compared to vasopressin receptors V1a (vascular/uterine) and V2 (renal), with much lower binding affinity, reducing the likelihood of significant interactions with vasopressin pathways.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5021139/)\n# Pharmacology\n\n### Mechanism of action\n\nCarbetocin works as an [oxytocic](Oxytocic \"Oxytocic\"), [antihemorrhagic](Antihemorrhagic \"Antihemorrhagic\") and [uterotonic](Uterotonic \"Uterotonic\") drug in the peripheral nervous system. The most common causes of [postpartum hemorrhage](Postpartum_hemorrhage \"Postpartum hemorrhage\") are lack of tone in the uterus from overstretching or the use of an anesthetic.[20]\n\nCarbetocin functions as an agonist at peripheral [oxytocin receptors](Oxytocin_receptor \"Oxytocin receptor\"), particularly in the myometrium. Oxytocin receptors are G protein-coupled[21] and their mechanism of action involves second messengers and the production of inositol phosphates.[16] Carbetocin mimics this mechanism.[22] Binding for carbetocin and other oxytocin agonists has been shown to be nonselective at the extracellular N-terminus and loops E2 and E3.[16] The oxytocin receptor shows similar affinity for oxytocin and carbetocin; clinically, carbetocin is as effective as oxytocin in preventing postpartum hemorrhage.[22][16] Carbetocin has a much longer lasting effect than oxytocin, necessitating only a single dose. Carbetocin is a [biased agonist](Biased_agonist \"Biased agonist\") of the oxytocin receptor.[23]\n\nDuring pregnancy, the synthesis of oxytocin receptors in the uterus greatly increases, reaching a peak during labor and delivery. Consequently, the administration of carbetocin or another oxytocin analog during or immediately following birth will have increased uterotonic and contractile effect. The application of carbetocin does not affect a non-pregnant uterus with lower oxytocin receptor expression.[9] Carbetocin should not be used to induce or augment labor since it could cause cardiac or respiratory distress to mother or infant.[8][9]\n\n### Pharmacokinetics\n\nCarbetocin is to be used in the hospital by prescription only. It can be administered intravenously or intramuscularly. In both cases, the recommended dose for an average adult female is 100 micrograms. Contractile effects of the uterus are apparent within two minutes and can be observed for approximately one hour,[17] though maximum binding occurs about 30 minutes after intramuscular injection. Administration is performed immediately following parturition to minimize risk of postpartum hemorrhage by inducing uterine contractions, increasing muscle tone. If further uterine stimulation is needed, treatment with other forms of [oxytocic](Oxytocic \"Oxytocic\") [uterotonic](Uterotonic \"Uterotonic\") drugs should be used.[17] A heat-stable formulation of carbetocin is available, which maintains efficacy without refrigeration requirements.[](https://www.who.int/news/item/05-10-2025-global-health-agencies-issue-new-recommendations-to-help-end-deaths-from-postpartum-haemorrhage)\n\nEndogenous and synthetic oxytocin has a half-life of approximately 3.5 minutes.[9][22] Carbetocin, in comparison, has a much longer half-life of approximately 40 minutes following intravenous administration (or 44-55 minutes intramuscular).[9][22] The bioavailable dose is around 80%.[10] The elimination half-life following intravenous administration is around 40 minutes, though the elimination mechanism is not entirely known.[17] Studies have shown that elimination is only minimally renal (0.7%), but may occur at least partially through enzymatic degradation of peptides, primarily on the C-terminal end.[22] Both elimination and volume of distribution are not dose dependent.[17]\n## Society and culture\n\n### Legal status\n\nCarbetocin is approved in more than 80 countries worldwide, excluding the United States and Japan. [](https://list.essentialmeds.org/recommendations/906) It is marketed under brand names such as Duratocin, Pabal, and Lonactene. A heat-stable formulation of carbetocin, suitable for use in low- and middle-income countries without cold chain requirements, has been approved in additional countries including India (2021), South Sudan, Sierra Leone, and is under registration in others as of 2024. [](https://www.biospace.com/women-in-india-are-the-first-in-the-world-to-receive-new-heat-stable-carbetocin-formulation-to-prevent-excessive-bleeding-after-childbirth) [](https://pmc.ncbi.nlm.nih.gov/articles/PMC12458669/) Duratocin is also approved for veterinary use in several European countries, including Poland, Germany, Italy, Belgium, Luxembourg, France, and the Netherlands. [](https://www.drugs.com/international/carbetocin.html)\n\n### Brand names\n\nDuratocin, Pabal, Lonactene (human use); Depotocin, Comoton, Decomoton (historical or veterinary)."])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"8:[\"$\",\"$L1e\",null,{\"state\":{\"mutations\":[],\"queries\":[{\"dehydratedAt\":1761885936467,\"state\":{\"data\":{\"page\":{\"citations\":[{\"id\":\"1\",\"title\":\"** MacDonald K, Feifel D (2015). [\\\"Helping Oxytocin Deliver: Considerations in the Development of Oxytocin-Based Therapeutics for Brain Disorders\\\"](https://books.google.com/books?id=QbA9CgAAQBAJ\u0026pg=PA51). In Shalev I, Ebstein RP (eds.). _Social Hormones and Human Behavior: What Do We Know and Where Do We Go from Here_. Frontiers Media SA. pp. 51â€“. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-2-88919-407-0.\",\"description\":\"1. **^** MacDonald K, Feifel D (2015). [\\\"Helping Oxytocin Deliver: Considerations in the Development of Oxytocin-Based Therapeutics for Brain Disorders\\\"](https://books.google.com/books?id=QbA9CgAAQBAJ\u0026pg=PA51). In Shalev I, Ebstein RP (eds.). _Social Hormones and Human Behavior: What Do We Know and Where Do We Go from Here_. Frontiers Media SA. pp. 51â€“. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-2-88919-407-0.\",\"url\":\"https://books.google.com/books?id=QbA9CgAAQBAJ\u0026pg=PA51\",\"favicon\":\"\"},{\"id\":\"2\",\"title\":\"_**a**_ _**b**_ _**c**_ _British National Formulary: BNF 76_ (76th ed.). Pharmaceutical Press. 2018. p. 804\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-85711-338-2.\",\"description\":\"2. ^ _**a**_ _**b**_ _**c**_ _British National Formulary: BNF 76_ (76th ed.). Pharmaceutical Press. 2018. p. 804\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-85711-338-2.\",\"url\":\"ISBN_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"3\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ [\\\"Proposal for Inclusion of Carbetocin in the Who List of Essential Medicines\\\"](https://www.who.int/selection_medicines/committees/expert/22/applications/s22.1_carbetocin.pdf) (PDF). _WHO_. Retrieved 25 October 2019.\",\"description\":\"3. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ [\\\"Proposal for Inclusion of Carbetocin in the Who List of Essential Medicines\\\"](https://www.who.int/selection_medicines/committees/expert/22/applications/s22.1_carbetocin.pdf) (PDF). _WHO_. Retrieved 25 October 2019.\",\"url\":\"https://www.who.int/selection_medicines/committees/expert/22/applications/s22.1_carbetocin.pdf\",\"favicon\":\"\"},{\"id\":\"4\",\"title\":\"** Morton IK, Hall JM (2012). [_Concise Dictionary of Pharmacological Agents: Properties and Synonyms_](https://books.google.com/books?id=tsjrCAAAQBAJ\u0026pg=PA65). Springer Science \u0026 Business Media. pp. 65â€“. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-94-011-4439-1.\",\"description\":\"4. **^** Morton IK, Hall JM (2012). [_Concise Dictionary of Pharmacological Agents: Properties and Synonyms_](https://books.google.com/books?id=tsjrCAAAQBAJ\u0026pg=PA65). Springer Science \u0026 Business Media. pp. 65â€“. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-94-011-4439-1.\",\"url\":\"https://books.google.com/books?id=tsjrCAAAQBAJ\u0026pg=PA65\",\"favicon\":\"\"},{\"id\":\"5\",\"title\":\"** Elks J (2014). [_The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies_](https://books.google.com/books?id=0vXTBwAAQBAJ\u0026pg=PA214). Springer. pp. 214â€“. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-4757-2085-3.\",\"description\":\"5. **^** Elks J (2014). [_The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies_](https://books.google.com/books?id=0vXTBwAAQBAJ\u0026pg=PA214). Springer. pp. 214â€“. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-4757-2085-3.\",\"url\":\"https://books.google.com/books?id=0vXTBwAAQBAJ\u0026pg=PA214\",\"favicon\":\"\"},{\"id\":\"6\",\"title\":\"** [World Health Organization](World_Health_Organization \\\"World Health Organization\\\") (2019). _World Health Organization model list of essential medicines: 21st list 2019_. Geneva: World Health Organization. [hdl](Hdl_\\\\(identifier\\\\) \\\"Hdl \\\\(identifier\\\\)\\\"):[10665/325771](https://hdl.handle.net/10665%2F325771). WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.\",\"description\":\"6. **^** [World Health Organization](World_Health_Organization \\\"World Health Organization\\\") (2019). _World Health Organization model list of essential medicines: 21st list 2019_. Geneva: World Health Organization. [hdl](Hdl_\\\\(identifier\\\\) \\\"Hdl \\\\(identifier\\\\)\\\"):[10665/325771](https://hdl.handle.net/10665%2F325771). WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.\",\"url\":\"World_Health_Organization \\\"World Health Organization\\\"\",\"favicon\":\"\"},{\"id\":\"7\",\"title\":\"** [\\\"Carbetocin Drug Information, Professional\\\"](https://web.archive.org/web/20201128074038/https://www.drugs.com/mmx/carbetocin.html). _Drugs.com_. Archived from [the original](https://www.drugs.com/mmx/carbetocin.html) on 28 November 2020. Retrieved 12 November 2019.\",\"description\":\"7. **^** [\\\"Carbetocin Drug Information, Professional\\\"](https://web.archive.org/web/20201128074038/https://www.drugs.com/mmx/carbetocin.html). _Drugs.com_. Archived from [the original](https://www.drugs.com/mmx/carbetocin.html) on 28 November 2020. Retrieved 12 November 2019.\",\"url\":\"https://web.archive.org/web/20201128074038/https://www.drugs.com/mmx/carbetocin.html\",\"favicon\":\"\"},{\"id\":\"8\",\"title\":\"_**a**_ _**b**_ _**c**_ Attilakos G, Psaroudakis D, Ash J, Buchanan R, Winter C, Donald F, et al. (July 2010). \\\"Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial\\\". _BJOG_. **117** (8): 929â€“936\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1471-0528.2010.02585.x](https://doi.org/10.1111%2Fj.1471-0528.2010.02585.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20482535](https://pubmed.ncbi.nlm.nih.gov/20482535). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [205616218](https://api.semanticscholar.org/CorpusID:205616218).\",\"description\":\"8. ^ _**a**_ _**b**_ _**c**_ Attilakos G, Psaroudakis D, Ash J, Buchanan R, Winter C, Donald F, et al. (July 2010). \\\"Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial\\\". _BJOG_. **117** (8): 929â€“936\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1471-0528.2010.02585.x](https://doi.org/10.1111%2Fj.1471-0528.2010.02585.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [20482535](https://pubmed.ncbi.nlm.nih.gov/20482535). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [205616218](https://api.semanticscholar.org/CorpusID:205616218).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"9\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Moertl MG, Friedrich S, Kraschl J, Wadsack C, Lang U, Schlembach D (October 2011). [\\\"Haemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomised trial\\\"](https://doi.org/10.1111%2Fj.1471-0528.2011.03022.x). _BJOG_. **118** (11): 1349â€“1356\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1471-0528.2011.03022.x](https://doi.org/10.1111%2Fj.1471-0528.2011.03022.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21668768](https://pubmed.ncbi.nlm.nih.gov/21668768). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [41172212](https://api.semanticscholar.org/CorpusID:41172212).\",\"description\":\"9. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Moertl MG, Friedrich S, Kraschl J, Wadsack C, Lang U, Schlembach D (October 2011). [\\\"Haemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomised trial\\\"](https://doi.org/10.1111%2Fj.1471-0528.2011.03022.x). _BJOG_. **118** (11): 1349â€“1356\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1471-0528.2011.03022.x](https://doi.org/10.1111%2Fj.1471-0528.2011.03022.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21668768](https://pubmed.ncbi.nlm.nih.gov/21668768). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [41172212](https://api.semanticscholar.org/CorpusID:41172212).\",\"url\":\"https://doi.org/10.1111%2Fj.1471-0528.2011.03022.x\",\"favicon\":\"\"},{\"id\":\"10\",\"title\":\"_**a**_ _**b**_ Silcox J, Schulz P, Horbay GL, Wassenaar W (September 1993). \\\"Transfer of carbetocin into human breast milk\\\". _Obstetrics and Gynecology_. **82** (3): 456â€“459\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [8355953](https://pubmed.ncbi.nlm.nih.gov/8355953).\",\"description\":\"10. ^ _**a**_ _**b**_ Silcox J, Schulz P, Horbay GL, Wassenaar W (September 1993). \\\"Transfer of carbetocin into human breast milk\\\". _Obstetrics and Gynecology_. **82** (3): 456â€“459\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [8355953](https://pubmed.ncbi.nlm.nih.gov/8355953).\",\"url\":\"PMID_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"11\",\"title\":\"** Bajcsy AC, Szenci O, van der Weijden GC, Doornenbal A, Maassen F, Bartyik J, Taverne MA (January 2006). \\\"The effect of a single oxytocin or carbetocin treatment on uterine contractility in early postpartum dairy cows\\\". _Theriogenology_. **65** (2): 400â€“414\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.theriogenology.2005.05.040](https://doi.org/10.1016%2Fj.theriogenology.2005.05.040). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15993938](https://pubmed.ncbi.nlm.nih.gov/15993938).\",\"description\":\"11. **^** Bajcsy AC, Szenci O, van der Weijden GC, Doornenbal A, Maassen F, Bartyik J, Taverne MA (January 2006). \\\"The effect of a single oxytocin or carbetocin treatment on uterine contractility in early postpartum dairy cows\\\". _Theriogenology_. **65** (2): 400â€“414\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.theriogenology.2005.05.040](https://doi.org/10.1016%2Fj.theriogenology.2005.05.040). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15993938](https://pubmed.ncbi.nlm.nih.gov/15993938).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"12\",\"title\":\"** Schramme AR, Pinto CR, Davis J, Whisnant CS, Whitacre MD (November 2008). \\\"Pharmacokinetics of carbetocin, a long-acting oxytocin analogue, following intravenous administration in horses\\\". _Equine Veterinary Journal_. **40** (7): 658â€“661\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2746/042516408X334343](https://doi.org/10.2746%2F042516408X334343). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19165935](https://pubmed.ncbi.nlm.nih.gov/19165935).\",\"description\":\"12. **^** Schramme AR, Pinto CR, Davis J, Whisnant CS, Whitacre MD (November 2008). \\\"Pharmacokinetics of carbetocin, a long-acting oxytocin analogue, following intravenous administration in horses\\\". _Equine Veterinary Journal_. **40** (7): 658â€“661\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.2746/042516408X334343](https://doi.org/10.2746%2F042516408X334343). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19165935](https://pubmed.ncbi.nlm.nih.gov/19165935).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"13\",\"title\":\"_**a**_ _**b**_ Widmer M, Piaggio G, Nguyen TM, Osoti A, Owa OO, Misra S, et al. (August 2018). [\\\"Heat-Stable Carbetocin versus Oxytocin to Prevent Hemorrhage after Vaginal Birth\\\"](https://doi.org/10.1056%2FNEJMoa1805489). _The New England Journal of Medicine_. **379** (8): 743â€“752\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMoa1805489](https://doi.org/10.1056%2FNEJMoa1805489). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [29949473](https://pubmed.ncbi.nlm.nih.gov/29949473). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [205103322](https://api.semanticscholar.org/CorpusID:205103322).\",\"description\":\"13. ^ _**a**_ _**b**_ Widmer M, Piaggio G, Nguyen TM, Osoti A, Owa OO, Misra S, et al. (August 2018). [\\\"Heat-Stable Carbetocin versus Oxytocin to Prevent Hemorrhage after Vaginal Birth\\\"](https://doi.org/10.1056%2FNEJMoa1805489). _The New England Journal of Medicine_. **379** (8): 743â€“752\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1056/NEJMoa1805489](https://doi.org/10.1056%2FNEJMoa1805489). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [29949473](https://pubmed.ncbi.nlm.nih.gov/29949473). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [205103322](https://api.semanticscholar.org/CorpusID:205103322).\",\"url\":\"https://doi.org/10.1056%2FNEJMoa1805489\",\"favicon\":\"\"},{\"id\":\"14\",\"title\":\"** Malm M, Madsen I, KjellstrÃ¶m J (June 2018). [\\\"Development and stability of a heat-stable formulation of carbetocin for the prevention of postpartum haemorrhage for use in low and middle-income countries\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001700). _Journal of Peptide Science_. **24** (6) e3082. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/psc.3082](https://doi.org/10.1002%2Fpsc.3082). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6001700](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001700). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [29700898](https://pubmed.ncbi.nlm.nih.gov/29700898).\",\"description\":\"14. **^** Malm M, Madsen I, KjellstrÃ¶m J (June 2018). [\\\"Development and stability of a heat-stable formulation of carbetocin for the prevention of postpartum haemorrhage for use in low and middle-income countries\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001700). _Journal of Peptide Science_. **24** (6) e3082. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/psc.3082](https://doi.org/10.1002%2Fpsc.3082). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6001700](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001700). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [29700898](https://pubmed.ncbi.nlm.nih.gov/29700898).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001700\",\"favicon\":\"\"},{\"id\":\"15\",\"title\":\"** Mundasad S (28 June 2018). [\\\"Revamped drug could save lives of many new mothers: WHO\\\"](https://www.bbc.com/news/world-asia-44617525). BBC News. Retrieved 28 June 2018.\",\"description\":\"15. **^** Mundasad S (28 June 2018). [\\\"Revamped drug could save lives of many new mothers: WHO\\\"](https://www.bbc.com/news/world-asia-44617525). BBC News. Retrieved 28 June 2018.\",\"url\":\"https://www.bbc.com/news/world-asia-44617525\",\"favicon\":\"\"},{\"id\":\"16\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Gimpl G, Postina R, Fahrenholz F, Reinheimer T (March 2005). \\\"Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin\\\". _European Journal of Pharmacology_. **510** (1â€“2): 9â€“16\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.ejphar.2005.01.010](https://doi.org/10.1016%2Fj.ejphar.2005.01.010). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15740719](https://pubmed.ncbi.nlm.nih.gov/15740719).\",\"description\":\"16. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Gimpl G, Postina R, Fahrenholz F, Reinheimer T (March 2005). \\\"Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin\\\". _European Journal of Pharmacology_. **510** (1â€“2): 9â€“16\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.ejphar.2005.01.010](https://doi.org/10.1016%2Fj.ejphar.2005.01.010). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [15740719](https://pubmed.ncbi.nlm.nih.gov/15740719).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"17\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ [\\\"Product Information - Duratocin\\\"](https://web.archive.org/web/20111115071733/http://secure.healthlinks.net.au/content/ferring/pi.cfm?product=fppdurai11007). _healthlinks.net_. Archived from the original on 15 November 2011. Retrieved 5 June 2012.\",\"description\":\"17. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ [\\\"Product Information - Duratocin\\\"](https://web.archive.org/web/20111115071733/http://secure.healthlinks.net.au/content/ferring/pi.cfm?product=fppdurai11007). _healthlinks.net_. Archived from the original on 15 November 2011. Retrieved 5 June 2012.\",\"url\":\"https://web.archive.org/web/20111115071733/http://secure.healthlinks.net.au/content/ferring/pi.cfm?product=fppdurai11007\",\"favicon\":\"\"},{\"id\":\"18\",\"title\":\"_**a**_ _**b**_ _**c**_ [\\\"Carbetocin\\\"](https://www.drugs.com/international/carbetocin.html). _drugs.com_. [Archived](https://web.archive.org/web/20160303223256/http://www.drugs.com/international/carbetocin.html) from the original on 3 March 2016. Retrieved 5 June 2012.\",\"description\":\"18. ^ _**a**_ _**b**_ _**c**_ [\\\"Carbetocin\\\"](https://www.drugs.com/international/carbetocin.html). _drugs.com_. [Archived](https://web.archive.org/web/20160303223256/http://www.drugs.com/international/carbetocin.html) from the original on 3 March 2016. Retrieved 5 June 2012.\",\"url\":\"https://www.drugs.com/international/carbetocin.html\",\"favicon\":\"\"},{\"id\":\"19\",\"title\":\"_**a**_ _**b**_ [\\\"Duratocin - Detailed Prescribing Information (Membership Required)\\\"](http://www.mims.com/Malaysia/drug/info/Duratocin/Duratocin%20infusion?type=full). _MIMS Malaysia_. [Archived](https://web.archive.org/web/20140117004458/https://member.ubmmedica.com/index.php?referrer=http%3A%2F%2Fwww.mims.com%2FMalaysia%2FSsoOtherMembership%2Findex%2F) from the original on 17 January 2014. Retrieved 5 June 2012.\",\"description\":\"19. ^ _**a**_ _**b**_ [\\\"Duratocin - Detailed Prescribing Information (Membership Required)\\\"](http://www.mims.com/Malaysia/drug/info/Duratocin/Duratocin%20infusion?type=full). _MIMS Malaysia_. [Archived](https://web.archive.org/web/20140117004458/https://member.ubmmedica.com/index.php?referrer=http%3A%2F%2Fwww.mims.com%2FMalaysia%2FSsoOtherMembership%2Findex%2F) from the original on 17 January 2014. Retrieved 5 June 2012.\",\"url\":\"http://www.mims.com/Malaysia/drug/info/Duratocin/Duratocin%20infusion?type=full\",\"favicon\":\"\"},{\"id\":\"20\",\"title\":\"** [\\\"Therapeutic Areas - Reproductive Health\\\"](https://web.archive.org/web/20120525031943/http://www.ferring.com/en/therapeutic/Reproductive_Health/Products/Obstetrics+Products.htm). _Ferring Pharmaceuticals_. Archived from [the original](http://ferring.com/en/therapeutic/Reproductive_Health/Products/Obstetrics+Products.htm) on 25 May 2012. Retrieved 5 June 2012.\",\"description\":\"20. **^** [\\\"Therapeutic Areas - Reproductive Health\\\"](https://web.archive.org/web/20120525031943/http://www.ferring.com/en/therapeutic/Reproductive_Health/Products/Obstetrics+Products.htm). _Ferring Pharmaceuticals_. Archived from [the original](http://ferring.com/en/therapeutic/Reproductive_Health/Products/Obstetrics+Products.htm) on 25 May 2012. Retrieved 5 June 2012.\",\"url\":\"https://web.archive.org/web/20120525031943/http://www.ferring.com/en/therapeutic/Reproductive_Health/Products/Obstetrics+Products.htm\",\"favicon\":\"\"},{\"id\":\"21\",\"title\":\"_**a**_ _**b**_ Gimpl G, Fahrenholz F (April 2001). \\\"The oxytocin receptor system: structure, function, and regulation\\\". _Physiological Reviews_. **81** (2): 629â€“683\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1152/physrev.2001.81.2.629](https://doi.org/10.1152%2Fphysrev.2001.81.2.629). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11274341](https://pubmed.ncbi.nlm.nih.gov/11274341). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [13265083](https://api.semanticscholar.org/CorpusID:13265083).\",\"description\":\"21. ^ _**a**_ _**b**_ Gimpl G, Fahrenholz F (April 2001). \\\"The oxytocin receptor system: structure, function, and regulation\\\". _Physiological Reviews_. **81** (2): 629â€“683\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1152/physrev.2001.81.2.629](https://doi.org/10.1152%2Fphysrev.2001.81.2.629). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11274341](https://pubmed.ncbi.nlm.nih.gov/11274341). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [13265083](https://api.semanticscholar.org/CorpusID:13265083).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"22\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ EngstrÃ¸m T, Barth T, Melin P, Vilhardt H (August 1998). \\\"Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation\\\". _European Journal of Pharmacology_. **355** (2â€“3): 203â€“210\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0014-2999(98)00513-5](https://doi.org/10.1016%2FS0014-2999%2898%2900513-5). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9760035](https://pubmed.ncbi.nlm.nih.gov/9760035).\",\"description\":\"22. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ EngstrÃ¸m T, Barth T, Melin P, Vilhardt H (August 1998). \\\"Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation\\\". _European Journal of Pharmacology_. **355** (2â€“3): 203â€“210\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/S0014-2999(98)00513-5](https://doi.org/10.1016%2FS0014-2999%2898%2900513-5). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9760035](https://pubmed.ncbi.nlm.nih.gov/9760035).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"23\",\"title\":\"** Gulliver D, Werry E, Reekie TA, Katte TA, Jorgensen W, Kassiou M (January 2019). [\\\"Targeting the Oxytocin System: New Pharmacotherapeutic Approaches\\\"](https://unsworks.unsw.edu.au/bitstreams/547ad575-bc60-4b4e-8bd3-681eff7ee47e/download). _Trends in Pharmacological Sciences_. **40** (1): 22â€“37\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.tips.2018.11.001](https://doi.org/10.1016%2Fj.tips.2018.11.001). [hdl](Hdl_\\\\(identifier\\\\) \\\"Hdl \\\\(identifier\\\\)\\\"):[1959.4/unsworks_81554](https://hdl.handle.net/1959.4%2Funsworks_81554). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30509888](https://pubmed.ncbi.nlm.nih.gov/30509888). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [54559394](https://api.semanticscholar.org/CorpusID:54559394).\",\"description\":\"23. **^** Gulliver D, Werry E, Reekie TA, Katte TA, Jorgensen W, Kassiou M (January 2019). [\\\"Targeting the Oxytocin System: New Pharmacotherapeutic Approaches\\\"](https://unsworks.unsw.edu.au/bitstreams/547ad575-bc60-4b4e-8bd3-681eff7ee47e/download). _Trends in Pharmacological Sciences_. **40** (1): 22â€“37\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.tips.2018.11.001](https://doi.org/10.1016%2Fj.tips.2018.11.001). [hdl](Hdl_\\\\(identifier\\\\) \\\"Hdl \\\\(identifier\\\\)\\\"):[1959.4/unsworks_81554](https://hdl.handle.net/1959.4%2Funsworks_81554). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30509888](https://pubmed.ncbi.nlm.nih.gov/30509888). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [54559394](https://api.semanticscholar.org/CorpusID:54559394).\",\"url\":\"https://unsworks.unsw.edu.au/bitstreams/547ad575-bc60-4b4e-8bd3-681eff7ee47e/download\",\"favicon\":\"\"}],\"images\":[],\"fixedIssues\":[{\"criticality\":\"Critical\",\"issueType\":\"Quantitative/Units Error\",\"problematicText\":\"Elimination half-life| 85â€“100 minutes[1]\",\"explanation\":\"The reported half-life of 85â€“100 minutes is inconsistent with primary pharmaceutical sources and product monographs, which indicate a terminal elimination half-life of approximately 40 minutes following intravenous administration (4â€“10 times longer than oxytocin's ~3â€“10 minutes). This discrepancy could mislead on pharmacokinetics, affecting clinical dosing or comparison to oxytocin. Ref [1] discusses oxytocin therapeutics and does not support the 85â€“100 minute claim for carbetocin.\",\"fixedText\":\"Correct to \\\"40 minutes (IV)\\\" and cite a reliable source such as the product monograph or DrugBank.\",\"evidenceSource\":\"Product monograph (Ferring, 2002): 41 Â± 11.9 minutes; DrugBank DB01282; multiple peer-reviewed studies (e.g., PMC6882650, ScienceDirect)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Elimination half-life| 85â€“100 minutes[1]\",\"explanation\":\"Reference [1] (MacDonald \u0026 Feifel, 2015) focuses on oxytocin-based therapeutics for brain disorders and does not provide pharmacokinetic data specific to carbetocin's half-life, leading to unsupported claim.\",\"fixedText\":\"Remove or replace citation [1] with an appropriate source supporting the corrected half-life.\",\"evidenceSource\":\"Ref [1] content: Discusses oxytocin delivery, not carbetocin PK details.\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"[No specific text; overall intro]\",\"explanation\":\"The intro omits mention of the heat-stable formulation of carbetocin, which is significant for its inclusion on the WHO Essential Medicines List (specifically for low- and middle-income countries) and addresses storage challenges in resource-limited settings. This gap affects completeness on medical uses and global accessibility as of 2023â€“2025 updates.\",\"fixedText\":\"Add brief note in medical uses paragraph: \\\"A heat-stable formulation is available for use in settings without cold chain.\\\"\",\"evidenceSource\":\"WHO Model List 23rd (2023); PMC12145113 (2025 review)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Some studies have shown that a 10-70 ug dose following vaginal delivery caused contractions and no adverse side effects.[10]\",\"explanation\":\"Reference [10] discusses transfer of carbetocin into breast milk after a 100 Î¼g IV dose post C-section, not low-dose IM administration post vaginal delivery or its effects on contractions/side effects.\",\"fixedText\":\"Replace [10] with a citation supporting the claim, such as [](https://www.tga.gov.au/sites/default/files/auspar-carbetocin-180823-cer.pdf), which references studies showing sustained contractions with 10-70 Î¼g IM post vaginal delivery.\",\"evidenceSource\":\"Existing ref 10\"},{\"criticality\":\"Critical\",\"issueType\":\"Mechanism/Specification Error\",\"problematicText\":\"Due to carbetocin's considerably longer half-life, its effects are longer lasting than other oxytocin homologs such as oxytocin or barusiban.[16]\",\"explanation\":\"Barusiban is an oxytocin receptor antagonist, not a homolog (structural analog agonist like carbetocin or oxytocin). Including it misrepresents its pharmacological role.\",\"fixedText\":\"Remove \\\"or barusiban\\\" to correctly list only agonist homologs.\",\"evidenceSource\":\"Existing ref 16 (compares barusiban as antagonist to agonists oxytocin and carbetocin)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"A single carbetocin dose compared to a placebo or an eight-hour intravenous drip of oxytocin in a randomized blind study, necessitated less additional oxytocin therapy following a Cesarean section.[16]\",\"explanation\":\"Reference [16] is a pharmacological study on receptor binding, not a clinical trial comparing doses or additional therapy needs. Additionally, placebo use would be unethical for PPH prevention; studies typically compare to oxytocin.\",\"fixedText\":\"Rephrase to reflect actual studies (e.g., single carbetocin vs. oxytocin infusion requires less additional uterotonics) and cite appropriate source, such as [](https://doi.org/10.1016/j.ajog.2004.04.019) for a relevant trial, or remove specific details if unsupported.\",\"evidenceSource\":\"Existing ref 16\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"No specific text; overall section lacks updates on heat-stable carbetocin.\",\"explanation\":\"Section mentions 2018 study but misses recent developments: heat-stable carbetocin prequalified by WHO in 2019, added to EML, implemented in LMICs as of 2024-2025 for vaginal births, with market authorization in 19 countries by March 2024.\",\"fixedText\":\"Add sentence in comparison subsection: \\\"Heat-stable carbetocin was prequalified by WHO in 2019 and, as of 2024, has market authorization in 19 countries for PPH prevention after vaginal birth.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC12458669/)\\\"\",\"evidenceSource\":\"[](https://www.who.int/news/item/27-06-2018-who-study-shows-new-drug-formulation-could-save-thousands-of-women-s-lives)\"},{\"criticality\":\"Critical\",\"issueType\":\"Safety/Health Risk\",\"problematicText\":\"Overdosage or repeated use of carbetocin, particularly if used during pregnancy, could cause hyper-excitation of the oxytocin receptors resulting in excessive and prolonged stimulation of uterine contractions, increasing risk of uterine rupture, placental abruption, fetal respiratory distress and postpartum hemorrhage.[17]\",\"explanation\":\"Carbetocin is used postpartum after delivery, so fetal respiratory distress and placental abruption are inapplicable as the fetus and placenta are already delivered. Postpartum hemorrhage is the condition it prevents, not a risk from overdose. It is contraindicated during pregnancy, so use during pregnancy is not relevant. Actual risks of overdosage include uterine hyperactivity, pain, hyponatremia, and water intoxication, per product information.\",\"fixedText\":\"Replace with: Overdosage of carbetocin may be associated with uterine hyperactivity and pain. Signs of overdose may arise from water intoxication and hyponatremia, especially with excessive fluid intake. Treatment consists of the administration of a dilute solution of ethanol, diuretics, supportive therapy, and symptomatic treatment of hyponatremia if needed. Remove references to pregnancy, uterine rupture, placental abruption, fetal respiratory distress, and postpartum hemorrhage. Cite the TGA PI or equivalent.\",\"evidenceSource\":\"TGA Product Information for Carbetocin[](https://www.tga.gov.au/sites/default/files/auspar-carbetocin-180823-pi.pdf)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Ten to forty percent of people will experience nausea, vomiting, abdominal pain, itching skin, increased body temperature, trembling and weakness. One to five percent of peoples may experience back and chest pain, dizziness, anemia, chills and sweating, metallic taste, tachycardia and respiratory distress.[17][18][19]\",\"explanation\":\"Citations [17][18][19] are archived pages from 2012 or earlier. Current product information (e.g., TGA 2018) categorizes frequent adverse effects (10-40%) as nausea, abdominal pain, pruritus, flushing, vomiting, feeling of warmth, hypotension, headache, tremor; infrequent (1-5%) as back pain, dizziness, metallic taste, anaemia, sweating, chest pain, dyspnoea, chills, tachycardia. \\\"Increased body temperature\\\" and \\\"weakness\\\" are not standard; \\\"anemia\\\" may be procedure-related, not drug-induced. Percentages in clinical data often exceed 40% for some (e.g., nausea 61%). Mismatch risks misleading on frequency and specific effects.\",\"fixedText\":\"Update lists to match current PI: Frequent (10-40% or greater in trials): nausea, vomiting, abdominal pain, itching (pruritus), flushing, feeling of warmth, headache, trembling (tremor). Infrequent (1-5%): back pain, chest pain, dizziness, chills, sweating, metallic taste, tachycardia, respiratory distress (dyspnoea), anaemia. Note similarity to placebo/oxytocin. Replace citations with current sources; correct \\\"peoples\\\" to \\\"people\\\".\",\"evidenceSource\":\"TGA Product Information for Carbetocin[](https://www.tga.gov.au/sites/default/files/auspar-carbetocin-180823-pi.pdf)\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"Additionally, carbetocin should not be used if a person has high blood pressure or cardiovascular problems.[17]\",\"explanation\":\"While cardiovascular disease is a contraindication, \\\"high blood pressure\\\" alone may not be absolute; severe hypertension or preeclampsia is cautioned, especially with vasoconstrictors. Sources specify cardiovascular disorders like coronary disease, valvular disease, cardiomyopathy, heart failure. Vague phrasing may overstate or understate applicability.\",\"fixedText\":\"Revise to: Carbetocin is contraindicated in patients with cardiovascular disease (e.g., coronary artery disease, valvular heart disease, cardiomyopathy, heart failure) and hypersensitivity to carbetocin or oxytocin. Use with caution in hypertension or preeclampsia.\",\"evidenceSource\":\"TGA Product Information for Carbetocin and BNF ref [2][](https://www.tga.gov.au/sites/default/files/auspar-carbetocin-180823-pi.pdf)\"},{\"criticality\":\"Non-Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"None\",\"explanation\":\"The section lacks mention that carbetocin's adverse effects profile is similar to oxytocin's and often comparable to placebo in clinical trials, which is key for context on safety.\",\"fixedText\":\"Add: Clinical trials show adverse effects of carbetocin are similar in type and frequency to those of oxytocin and often no different from placebo.\",\"evidenceSource\":\"WHO application ref [3] and Cochrane review[](https://www.who.int/selection_medicines/committees/expert/22/applications/s22.1_carbetocin.pdf)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Due to oxytocin's close sequence [homology](Homologous_series \\\"Homologous series\\\") with [vasopressin](Vasopressin \\\"Vasopressin\\\"), [oxytocin](Oxytocin \\\"Oxytocin\\\") analogs often bind with much lower affinity to vasopressin receptors V1, in the uterine lining, and V2, in the kidneys[19]\",\"explanation\":\"The citation [19] refers to prescribing information for Duratocin, which states no specific drug interactions have been reported with carbetocin and does not mention binding affinities to vasopressin receptors. This claim is unsupported by the cited source.\",\"fixedText\":\"Remove or relocate the citation [19] from this claim. Verify and cite a pharmacological source if retaining, such as a peer-reviewed study on receptor affinities.\",\"evidenceSource\":\"[19]; Ferring Canada PI for Duratocin (2024) states \\\"No specific drug interactions have been reported with carbetocin.\\\"\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"Concurrent use of these drugs can be risky, particularly during pregnancy and prenatal care, possibly causing premature labor or abortion.\",\"explanation\":\"Carbetocin is indicated only for postpartum use to prevent hemorrhage after delivery (e.g., after cesarean section). It is contraindicated during pregnancy or before delivery due to risks like uterine hyperstimulation. The claim misapplies risks to inappropriate contexts (pregnancy/prenatal care), where carbetocin is not used, potentially misleading on usage and safety.\",\"fixedText\":\"Clarify that carbetocin is postpartum only and remove references to risks during pregnancy/prenatal care. Note potential interactions with prostaglandins in postpartum context if concurrent use occurs.\",\"evidenceSource\":\"Ferring Canada PI for Duratocin (2024): Contraindicated prior to infant delivery; TGA Australia PI (2018): Similar contraindications.\"},{\"criticality\":\"Critical\",\"issueType\":\"Mechanism/Specification Error\",\"problematicText\":\"and may consequently interact with or disrupt the vasopressin circuitry and feedback loops.\",\"explanation\":\"Carbetocin is designed with lower affinity for vasopressin receptors (V1a/V2) compared to oxytocin receptors, making significant interaction or disruption unlikely at therapeutic doses. This claim overstates potential effects without evidence, as studies show carbetocin is selective and inactive at vasopressin receptors even at high concentrations.\",\"fixedText\":\"Remove the speculative disruption claim or qualify it as theoretical and low risk based on selectivity.\",\"evidenceSource\":\"\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"[Entire section lacks specific interactions]\",\"explanation\":\"The section omits documented potential interactions from prescribing information, such as potentiation of effects with prostaglandins (e.g., dinoprostone, misoprostol) or vasoconstrictors, and cumulative effects with other uterotonics like oxytocin or ergometrine. This creates knowledge gaps on actual clinical considerations.\",\"fixedText\":\"Add summary of known potential interactions from authoritative sources, citing PIs, to ensure completeness without speculation.\",\"evidenceSource\":\"Ferring Canada PI (2024): Prostaglandins potentiate effects; risk of cumulative effect with oxytocin/methylergometrine.\"},{\"criticality\":\"Critical\",\"issueType\":\"Quantitative/Units Error\",\"problematicText\":\"Carbetocin, in comparison, has a much longer half-life ranging from 85 to 100 minutes.[9][22]\",\"explanation\":\"Internal contradiction within section (later states IV half-life ~40 min). Modern sources consistently report elimination half-life of ~40 minutes for IV administration (4-10 times longer than oxytocin's ~3-5 min), with IM slightly longer (~50-60 min). Cited refs [9] and [22] support ~40 min or cite outdated 1981 data; using 85-100 min misleads on duration and could affect clinical understanding.\",\"fixedText\":\"Correct to: elimination half-life of approximately 40 minutes (IV) or 44-55 minutes (IM).\",\"evidenceSource\":\"Ref [9] (Moertl et al., 2011); WHO recommendations; DrugBank\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"While the oxytocin receptor shows equal affinity for oxytocin and carbetocin, the biological effect of carbetocin is almost 50% that of endogenous or exogenous oxytocin.[22][16]\",\"explanation\":\"Citations [22] and [16] refer to in vitro binding/uterotonic activity, but clinical evidence shows carbetocin is equivalent to oxytocin in preventing postpartum hemorrhage. Claim misrepresents efficacy, potentially implying inferiority despite equivalent clinical outcomes.\",\"fixedText\":\"Revise to: The oxytocin receptor shows similar affinity for oxytocin and carbetocin; clinically, carbetocin is as effective as oxytocin in preventing postpartum hemorrhage.\",\"evidenceSource\":\"Ref [3] (WHO proposal); meta-analyses (e.g., Cochrane reviews on carbetocin vs oxytocin)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Carbetocin also functions to thicken the blood, further preventing post-partum hemorrhage.[18]\",\"explanation\":\"Citation [18] (drugs.com) does not mention blood thickening; carbetocin's antihemorrhagic effect is solely via uterine contraction, not hemostasis or blood viscosity changes. Unsupported claim could mislead on mechanism.\",\"fixedText\":\"Remove the sentence.\",\"evidenceSource\":\"Browse of drugs.com; pharmacology reviews (e.g., DrugBank, WHO)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Carbetocin inhibits endogenous oxytocin release, interrupting the uterine feedback loop with the hypothalamus and decreasing both central and peripheral release of oxytocin.[21]\",\"explanation\":\"Citation [21] (Gimpl 2001) discusses oxytocin receptor generally, not carbetocin's effect on endogenous release. No primary evidence supports this for carbetocin; claim appears unsubstantiated and could confuse pharmacology.\",\"fixedText\":\"Remove the sentence.\",\"evidenceSource\":\"Ref [21]; search yields no confirmation\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Carbetocin functions as an agonist at peripheral oxytocin receptors, particularly in the myometrium, with lesser affinity for myoepithelial cells.\",\"explanation\":\"No cited source; evidence shows carbetocin acts on myoepithelial cells to stimulate milk letdown, similar to oxytocin. \\\"Lesser affinity\\\" is unsupported and contradicts studies.\",\"fixedText\":\"Remove \\\"with lesser affinity for myoepithelial cells.\\\"\",\"evidenceSource\":\"Studies on milk letdown (e.g., Comparative study, Egyptian J Anaesthesia 2015)\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"[None - gap identification]\",\"explanation\":\"Section omits mention of heat-stable carbetocin formulation, approved for use in low-resource settings (WHO EML 2019, recent 2025 recommendations). Relevant to pharmacokinetics as it does not require cold chain, affecting stability and accessibility without altering core PK.\",\"fixedText\":\"Add brief note in Pharmacokinetics: A heat-stable formulation of carbetocin is available, which maintains efficacy without refrigeration requirements.\",\"evidenceSource\":\"Ref [13], [14]; WHO 2025 PPH recommendations\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"Carbetocin has been approved for use under the following three brand names in 23 countries: Duratocin (Argentina, Australia, Bahrain, Canada, China, Hong Kong, Italy, Malaysia, Singapore, New Zealand), Lonactene (Mexico), and Pabal (Austria, Belgium, Switzerland, Germany, Estonia, France, UK, Hungary, Lithuania, Luxembourg, Finland).\",\"explanation\":\"The provided list and count of 23 countries are based on outdated information from around 2012 (ref [18], archived 2016). As of 2023-2025, carbetocin is approved in more than 80 countries worldwide, excluding the US and Japan, including expanded approvals for heat-stable formulations in low- and middle-income countries.\",\"fixedText\":\"Update to state that carbetocin is approved in more than 80 countries worldwide (excluding the US and Japan), with examples of brand names and countries where applicable. Note the expansion due to heat-stable formulation. Remove or generalize the specific outdated list. Retain or update citation if possible, add new sources.\",\"evidenceSource\":\"[](https://list.essentialmeds.org/recommendations/906); [](https://www.sciencedirect.com/topics/medicine-and-dentistry/carbetocin); [](https://www.ferring.com/wp-content/uploads/sites/16/2019/06/090719-ferring-press-release-heat-stable-carbetocin-added-to-eml.pdf)\"},{\"criticality\":\"Critical\",\"issueType\":\"Quantitative/Units Error\",\"problematicText\":\"in 23 countries\",\"explanation\":\"The count of 23 countries is incorrect and outdated; current approvals exceed 80 countries. The listed countries total 22 (if counting Hong Kong separately), already inconsistent internally.\",\"fixedText\":\"Replace with accurate current estimate: more than 80 countries.\",\"evidenceSource\":\"[](https://list.essentialmeds.org/recommendations/906)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Duratocin has also been approved for veterinary use in Poland, Germany, Italy, Belgium, Luxembourg, France and the Netherlands.[18]\",\"explanation\":\"Reference [18] is an outdated drugs.com page (archived 2016) that may no longer accurately reflect current veterinary approvals, which could have changed or expanded. No recent confirmation of this exact list.\",\"fixedText\":\"Verify and update veterinary approvals; if unconfirmed, generalize to \\\"several European countries\\\" or remove if not critical. Add current source if available.\",\"evidenceSource\":\"[18]; [](https://www.uochb.cz/en/oxitocin-carbetocin)\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"[Entire Legal status subsection]\",\"explanation\":\"The subsection lacks mention of the heat-stable carbetocin formulation, which has been a significant development since 2018 (WHO EML addition), with approvals in additional LMICs like India (2021), South Sudan, Sierra Leone, and ongoing registrations in others as of 2024-2025. This is a key knowledge gap affecting completeness and currency.\",\"fixedText\":\"Add information on heat-stable carbetocin approvals and its role in expanding access in low-resource settings.\",\"evidenceSource\":\"[](https://www.who.int/selection_medicines/committees/expert/22/applications/s22.1_carbetocin.pdf); [](https://www.biospace.com/women-in-india-are-the-first-in-the-world-to-receive-new-heat-stable-carbetocin-formulation-to-prevent-excessive-bleeding-after-childbirth); [](https://pmc.ncbi.nlm.nih.gov/articles/PMC12458669/)\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"Duratocin, Pabal, Lonactene, Depotocin, Comoton, and Decomoton.\",\"explanation\":\"Brand names subsection is unsourced and includes potentially obscure or historical brands (Depotocin, Comoton, Decomoton) without context. Decomoton is confirmed as veterinary (e.g., in Spain, Philippines). Lacks currency and distinction between human/veterinary use.\",\"fixedText\":\"Specify primary human brands from reliable sources; note veterinary brands separately. Add source.\",\"evidenceSource\":\"[](https://www.calier.com/en/vademecum/decomoton); [](https://verification.fda.gov.ph/ALL_DrugProductslist.php/ALL_DrugProductsview.php?showdetail=\u0026registration_number=VR-3116)\"}],\"slug\":\"Carbetocin\",\"title\":\"Carbetocin\",\"content\":\"$1f\",\"description\":\"Carbetocin\\n\\n| Attribute | Details |\\n|---------------|-------------|\\n| Trade names | Duratocin, Pabal, Lonactene, others |\\n| Other names | (2-O-Methyltyrosine)deamino-1-carbaoxytocin;...\",\"metadata\":{\"categories\":[],\"lastModified\":\"1761553160\",\"contentLength\":\"13994\",\"version\":\"1.0\",\"lastEditor\":\"system\",\"language\":\"en\",\"isRedirect\":false,\"redirectTarget\":\"\",\"isWithheld\":false},\"stats\":{\"totalViews\":\"19297\",\"recentViews\":\"19297\",\"dailyAvgViews\":643.2333374023438,\"qualityScore\":1,\"lastViewed\":\"1761885936\"},\"linkedPages\":null},\"found\":true},\"dataUpdateCount\":1,\"dataUpdatedAt\":1761885936466,\"error\":null,\"errorUpdateCount\":0,\"errorUpdatedAt\":0,\"fetchFailureCount\":0,\"fetchFailureReason\":null,\"fetchMeta\":null,\"isInvalidated\":false,\"status\":\"success\",\"fetchStatus\":\"idle\"},\"queryKey\":[\"page\",\"Carbetocin\"],\"queryHash\":\"[\\\"page\\\",\\\"Carbetocin\\\"]\"}]},\"children\":\"$L20\"}]\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"c:{\"metadata\":[[\"$\",\"title\",\"0\",{\"children\":\"Carbetocin\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"Carbetocin , sold under the brand names Pabal among others, is a medication used to prevent excessive bleeding after childbirth, particularly following Cesarean section.[2] It appears to work as well as oxytocin.[3] Due to it being less economical than other options, use is not recommended by NHS Scotland.[2] It is given by injection into a vein or muscle.[3] A heat-stable formulation is available for prevention of postpartum hemorrhage in low-resource settings without reliable cold chain.[3]...\"}],[\"$\",\"meta\",\"2\",{\"name\":\"author\",\"content\":\"system\"}],[\"$\",\"link\",\"3\",{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\",\"crossOrigin\":\"$undefined\"}],[\"$\",\"meta\",\"4\",{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",\"5\",{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"link\",\"6\",{\"rel\":\"canonical\",\"href\":\"https://grokipedia.com/page/Carbetocin\"}],[\"$\",\"meta\",\"7\",{\"property\":\"og:title\",\"content\":\"Carbetocin\"}],[\"$\",\"meta\",\"8\",{\"property\":\"og:description\",\"content\":\"Carbetocin , sold under the brand names Pabal among others, is a medication used to prevent excessive bleeding after childbirth, particularly following Cesarean section.[2] It appears to work as well as oxytocin.[3] Due to it being less economical than other options, use is not recommended by NHS Scotland.[2] It is given by injection into a vein or muscle.[3] A heat-stable formulation is available for prevention of postpartum hemorrhage in low-resource settings without reliable cold chain.[3]...\"}],[\"$\",\"meta\",\"9\",{\"property\":\"og:url\",\"content\":\"https://grokipedia.com/page/Carbetocin\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:locale\",\"content\":\"en\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",\"13\",{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",\"14\",{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",\"15\",{\"property\":\"og:image:alt\",\"content\":\"Carbetocin\"}],[\"$\",\"meta\",\"16\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"17\",{\"property\":\"article:modified_time\",\"content\":\"1970-01-21T09:19:13.160Z\"}],[\"$\",\"meta\",\"18\",{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",\"19\",{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",\"20\",{\"name\":\"twitter:title\",\"content\":\"Carbetocin\"}],[\"$\",\"meta\",\"21\",{\"name\":\"twitter:description\",\"content\":\"Carbetocin , sold under the brand names Pabal among others, is a medication used to prevent excessive bleeding after childbirth, particularly following Cesarean section.[2] It appears to work as well as oxytocin.[3] Due to it being less economical than other options, use is not recommended by NHS Scotland.[2] It is given by injection into a vein or muscle.[3] A heat-stable formulation is available for prevention of postpartum hemorrhage in low-resource settings without reliable cold chain.[3]...\"}],[\"$\",\"meta\",\"22\",{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"link\",\"23\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"$L21\",\"24\",{}]],\"error\":null,\"digest\":\"$undefined\"}\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"11:\"$c:metadata\"\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"22:I[61172,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"PageEditorProvider\"]\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"23:I[63493,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="MDQ3ZmI2MTktYjQxNC00ZTI1LTg3M2ItN2NhYTQ2OWRjYTFh">self.__next_f.push([1,"20:[\"$\",\"$L22\",null,{\"children\":[\"$\",\"$L23\",null,{\"slug\":\"Carbetocin\"}]}]\n"])</script></body></html>